Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

Fecal Microbiota Transplantation (FMT) & Melanoma (cutaneous)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

Fecal Microbiota Transplantation (FMT) is emerging as a plausible strategy to (partly) overcome resistance to PD‑1–based immunotherapy in advanced cutaneous melanoma, with several small trials showing meaningful response rates but still limited sample sizes and no regulatory approval
Davar et al., 2021 Science 371: 595-602
Vongsavath et al. 2024 Cancers (Basel) 16(3): 499

Randomized clinical trials (RCTs)

NCT04577729
No published results were found as of May 2026

[NCT05251389](brain://wYCJ1…

References (Sources)

Fecal microbiota transplant overcomes resistance to anti–PD-1 therapy in melanoma patients
Davar et al., 2021 Science 371: 595-602
The Use of Fecal Microbiota Transplant in Overcoming and Modulating Resistance to Anti-PD-1 Therapy in Patients with Skin Cancer
Vongsavath et al. 2024 Cancers (Basel) 16(3): 499
Review

AI Chat

7/1/2026

Chat with our artificial intelligence:

Start chat!